WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases

Conditions:   Anaplastic Astrocytoma, IDH-Wildtype;   Glioblastoma, IDH-Wildtype;   Lung Non-Small Cell Carcinoma;   Metastatic Malignant Neoplasm in the Central Nervous System;   Metastatic Malignant Neoplasm in the Leptomeninges Interventions:   Drug: EGFR/EGFRvIII Inhibitor WSD0922-FU;   Procedure: Therapeutic Conventional Surgery Sponsors:   Mayo Clinic;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials